Professor Carolyn Sue
“Currently, all treatments are aimed at reducing the symptoms of the condition. This project however, will look to halt the symptoms and reduce the progression of the disease.” The large scale screening campaign will be carried out over the coming months.
Kolling, where we are able to directly transfer our breakthroughs in research into better treatment options for patients and ultimately better health outcomes.” Professor Sue said the project was a wonderful opportunity to work collaboratively with the National Drug Discovery Centre team at the Walter and Eliza Hall Institute. “This is a tremendously exciting project as it’s investigating new ways to treat Parkinson’s disease.
“This approach will give us the best chance of identifying the most effective compounds for new drug therapies. “I’m looking forward to working with Professor Carolyn Sue, Dr Gautam Wali and Professor Michael Kassiou from the University of Sydney on this exciting project. “It is an important step in the development of new treatments for Parkinson’s disease and highlights the translational strength of the
7
WWW.KOLLINGINSTITUTE.ORG.AU
Made with FlippingBook - professional solution for displaying marketing and sales documents online